Page last updated: 2024-12-05

valeramide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Valeramide is a white, crystalline solid with a mild odor. It is a derivative of valeric acid, a naturally occurring fatty acid. Valeramide is synthesized by reacting valeric acid with ammonia. It has been investigated for its potential therapeutic effects, including its ability to reduce anxiety, promote sleep, and alleviate pain. It is thought to exert its effects by interacting with neurotransmitters in the brain, particularly GABA. Research suggests that valeramide may have anticonvulsant properties and could be beneficial in managing epilepsy. However, more research is needed to fully understand its efficacy and safety.'

pentanamide : A monocarboxylic acid amide obtained by the formal condensation of valeric acid with ammonia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12298
CHEBI ID16459
SCHEMBL ID20284
MeSH IDM0157310

Synonyms (36)

Synonym
einecs 210-974-0
tkl9tn43qk ,
unii-tkl9tn43qk
ai3-24387
nsc 400223
AKOS009031546
EN300-19981
CHEBI:16459
LMFA08010002
nsc400223
n-valeramide
nsc-400223
pentanimidic acid
pentanamide
626-97-1
valeramide
C01842
inchi=1/c5h11no/c1-2-3-4-5(6)7/h2-4h2,1h3,(h2,6,7)
ipwfjlqdvfkjdu-uhfffaoysa-
V0002
A833929
STL283920
FT-0603495
SCHEMBL20284
valeric acid amide
valproic acid impurity e [ep impurity]
DTXSID3060827
valeramide, pharmaceutical impurity standard
mfcd00041895
pentanamide (valeramide)
pentanamide; valproic acid imp. e (ep); valeramide; valproic acid impurity e
Q6071464
ch3(ch2)3c(o)nh2
CS-0206049
FS-4458
Z104476278
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.63 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]